Sosei Group (JP:4565) has released an update.
Nxera Pharma Co., Ltd, formerly known as Sosei Group Corporation, reported a substantial year-on-year revenue increase to 12,720 million yen for the first half of 2024, but also a net loss of 4,703 million yen. The company’s equity has risen to 68,980 million yen, comprising 44.1% of total assets. Due to the difficulty in forecasting, no full-year financial results estimate for 2024 has been provided.
For further insights into JP:4565 stock, check out TipRanks’ Stock Analysis page.
